CFO transition ahead: Symrise stock slips to EUR 95.51, down 0.53%
Published on 11/17/2026 at 08:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Matters for Symrise Investors
- Symrise is scheduled to hold a US roadshow on Tuesday, November 17, 2026.
- The company reported EUR 4,929 million in 2025 revenue and 2.8 percent organic growth.
- Symrise announced a CFO change and extended Walter Ribeiro's board mandate on November 10, 2026.
Symrise stock traded at EUR 95.51 on Lang & Schwarz at 08:20:55 CET on Tuesday, November 17, 2026, 0.53 percent below the Xetra close of Monday, November 16, 2026.
Business and Upcoming Dates
Symrise supplies fragrances, flavorings, cosmetic ingredients and functional ingredients to customers in the perfume, cosmetics, food, beverage, pharmaceutical, supplement and pet-food industries.
The company is scheduled to hold a US roadshow on Tuesday, November 17, 2026. Its investor relations calendar lists the event alongside financial publications and capital-market information.
Symrise reported EUR 4,929 million in 2025 revenue, 2.8 percent organic growth and a 21.9 percent EBITDA margin excluding the impairment of its associate Swedencare, according to Symrise investor relations.
On November 10, 2026, the company announced a CFO change and an extension of Walter Ribeiro's executive-board mandate.
The DAX provides the relevant German market context for Symrise investors.
